Dopamine-mediated inhibition of renal Na+/K+-ATPase in HK-2 cells is reduced by ouabain

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 5-6, 2010, Pages 613-618

  Zhang, Yu Rong ^a   Yuan, Zu Yi ^a,b  

^a First Affiliated Hospital   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Ouabain; Renal tubular epithelial cell; Sodium transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLIC AMP; DOPAMINE 1 RECEPTOR; FENOLDOPAM; MESSENGER RNA; OUABAIN; CARDIOTONIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; SODIUM;

ARTICLE; BIOACCUMULATION; CHRONIC DRUG ADMINISTRATION; COLORIMETRY; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERTENSION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE CELL; LONG TERM EXPOSURE; POTASSIUM TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; IMMUNOPRECIPITATION; ION TRANSPORT; KIDNEY PROXIMAL TUBULE; METABOLISM; PHOSPHORYLATION;

BLOTTING, WESTERN; CARDIOTONIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE; CYCLIC AMP; DOPAMINE; DOPAMINE AGONISTS; FENOLDOPAM; HUMANS; HYPERTENSION; IMMUNOPRECIPITATION; ION TRANSPORT; KIDNEY TUBULES, PROXIMAL; OUABAIN; PHOSPHORYLATION; RECEPTORS, DOPAMINE D1; RNA, MESSENGER; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 77951113453     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05364.x     Document Type: Article

References (33)

1. Schoner W. Endogenous cardiac glycosides: A new class of steroid hormones. Eur. J. Biochem. 2002 269 : 2440 2448.
2. Aperia A. Regulation of sodium/potassium ATPase activity: Impact on salt balance and vascular contractility. Curr. Hypertens. Rep. 2001 3 : 165 171.
3. Manunta P, Ferrandi M, Messaggio E, Ferrari P. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin. Cardiovasc. Hematol. Agents. Med. Chem. 2006 4 : 61 6.
4. Hamlyn JM, Hamilton BP, Manunta P. Endogenous ouabain, sodium balance and blood pressure: A review and a hypothesis. J. Hypertens. 1996 14 : 151 167.
5. Yuan CM, Manunta P, Hamlyn JM et al. Long term ouabain administration produces hypertension in rats. Hypertension 1993 22 : 178 187.
6. Huang BS, Leenen FH. Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 1999 34 : 107 112.
7. Rossoni LV, Cunha V, Franca A, Vassallo DV. The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J. Cardiovasc. Pharmacol. 1999 34 : 887 892.
8. Bie P, Damkjaer M. Renin secretion and total body sodium: Pathways of integrative control. Clin. Exp. Pharmacol. Physiol. 2010 37 : e34 42.
9. Ferrandi M, Barassi P, Molinari I et al. Ouabain antagonists as antihypertensive agents. Curr. Pharm. Des. 2005 11 : 3301 3305.
10. Ge H, Lü ZR. Changes in renal sodium transport during hypertension development in ouabain-hypertensive rats. Nan Fang Yi Ke Da Xue Xue Bao 2006 26 : 1404 1407.
11. Felder RA, Eisner GM, Jose PA. D1 dopamine receptor signaling defect in spontaneous hypertension. Acta Physiol. Scand. 2000 168 : 245 250.
12. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr. Opin. Nephrol. Hypertens. 2002 11 : 87 92.
13. Sanada H, Jose PA, Harzen-Martin D et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999 33 : 1036 1042.
14. Ferrari P, Torielli L, Ferrandi M et al. PST 2238: A new antihypersive compound that antagonizes the long-term pressor effect of ouabain. J. Pharmacol. Exp. Ther. 1998 285 : 83 94.
15. Banday AA, Fazili FR, Lokhandwala MF. Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. Am. J. Physiol. Renal Physiol. 2007 293 : F877 84.
16. Tian G, Dang C, Lu Z. The change and significance of the Na +-K+-ATPase alpha-subunit in ouabain-hypertensive rats. Hypertens. Res. 2001 24 : 729 734.
17. Doris PA. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J. Hypertens. 2000 18 : 509 519.
18. Eklof AC, Holtback U, Sundelof M, Chen S, Aperia A. Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase. Kidney Int. 1997 52 : 742 747.
19. Padilha AS, Moreira CM, Meira EF, Siman FD, Stefanon I, Vassallo DV. Chronic ouabain treatment enhances cardiac myosin ATPase activity in rats. Clin. Exp. Pharmacol. Physiol. 2008 35 : 801 806.
20. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: Their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 2007 293 : C509 36.
21. Jose PA, Eisner GM, Felder RA. Renal dopamine and sodium homeostasis. Curr. Hypertens. Rep. 2000 2 : 174 183.
22. Zhang Y, Yuan Z, Ge H, Ren Y. Effects of long-term ouabain treatment on blood pressure, sodium excretion, and renal dopamine D(1) receptor levels in rats. J. Comp. Physiol. B. 2010 180 : 117 124.
23. Yao LP, Li XX, Yu PY, Xu J, Asico LD, Jose PA. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998 32 : 1049 1053.
24. Banday AA, Lau YS, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008 51 : 367 375.
25. Nishi A, Eklof AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na+,K(+)- ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993 21 : 767 771.
26. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sci. U S A 1995 92 : 2924 2928.
27. Yu P, Asico LD, Luo Y et al. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int. 2006 70 : 1072 1079.
28. Asghar M, Hussain T, Lokhandwala MF. Higher basal serine phosphorylation of D1A receptors in proximal tubules of old Fischer 344 rats. Am. J. Physiol. Renal Physiol. 2002 283 : F350 5.
29. Sanada H, Yatabe J, Midorikawa S et al. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 2006 47 : 1131 1139.
30. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 1998 38 : 289 319.
31. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002 3 : 639 650.
32. Haas M, Wang H, Tian J, Xie Z. Src-mediated inter-receptor cross-talk between the Na/K-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002 21 : 18694 18702.
33. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: Their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 2007 2 : C509 36.